https://www.taylorcollison.com.au/wp-content/uploads/2021/07/IMM-20210706-Upgrade.pdf
Efti development program expanded
Our View
IMM has announced plans to expand the clinical program for efti funded by a $65m capital raise. Key additions are i) a Phase III trial of efti plus paclitaxel in metastatic breast cancer (mBC); and ii) a Phase II trial of efti/chemo/anti-PD1 triple combo in non-small cell lung cancer (NSCLC). The recent GSK/Iteos licence deal, which included US$625m upfront and total deal value over US$2bn for a Phase I TIGIT drug highlights the value big pharma attributes to promising immuno-oncology (IO) combo therapies, and indicates the potential value of efti if it demonstrates efficacy in the planned TACTI-003 randomised Phase IIb in head and neck cancer.
We revise our risk-adjusted valuation of IMM, adding the mBC Phase III (risked to 25%), updating the upfront and milestone payments from a potential efti licence deal in light of the GSK/iTeos deal and increasing modelled royalty rates. Our post cap raise valuation increases to $1,002m (vs $714m), $1.14/sh fully diluted (vs $1.00/sh) or $1.19/sh undiluted.
- Forums
- ASX - By Stock
- IMM
- Ann: Immutep Capital Raising Presentation
Ann: Immutep Capital Raising Presentation, page-140
-
-
- There are more pages in this discussion • 71 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
35.5¢ |
Change
0.060(20.3%) |
Mkt cap ! $515.6M |
Open | High | Low | Value | Volume |
36.0¢ | 37.5¢ | 33.5¢ | $6.427M | 18.03M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 35.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.0¢ | 133736 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.355 |
2 | 9500 | 0.350 |
4 | 199315 | 0.345 |
10 | 84868 | 0.340 |
2 | 10985 | 0.335 |
Price($) | Vol. | No. |
---|---|---|
0.360 | 96182 | 4 |
0.365 | 81517 | 4 |
0.370 | 150545 | 8 |
0.375 | 156434 | 4 |
0.380 | 167642 | 11 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |